CRISPR is a form of gene editing that has revolutionised the field of genetics. Previously, creating genetically modified organisms took a considerable amount of time and money. CRISPR has changed that, with the potential to change the way we look at medicine.
The FDA has approved a new drug for the prevention of malaria. ARAKODA™, the brand name for Tafenoquine, will be produced in tablet form and used by those over the age of 18. Its approval presents a milestone after years of research and discovery in the antimalarial field.